The Trump administration and the House have wisely decided not to risk the destruction of the individual market at this point. The administration has apparently reimbursed the insurers for February and will likely keep paying them until the matter is resolved. The House has never opposed paying the cost-sharing reduction payments, but has rather insisted that they not be paid unless Congress appropriates the money to fund them. The abeyance will give Congress time to do this.
healthaffairs.org |
